Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.

CA, Taylor; K, Patel; H, Pham; M, Whitaker; O, Anglin; AK, Kambhampati; J, Milucky; SJ, Chai; PD, Kirley; NB, Alden; I, Armistead; J, Meek; K, Yousey-Hindes; EJ, Anderson; KP, Openo; K, Teno; A, Weigel; ML, Monroe; PA, Ryan; J, Henderson; VT, Nunez; E, Bye; R, Lynfield; M, Poblete; C, Smelser; GR, Barney; NL, Spina; NM, Bennett; K, Popham; LM, Billing; E, Shiltz; N, Abdullah; M, Sutton; W, Schaffner; HK, Talbot; J, Ortega; A, Price; S, Garg; FP, Havers

doi:10.15585/mmwr.mm7043e1

Public

Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.

Published in MMWR. Morbidity and mortality weekly report • Oct 29, 2021

Authors:

Taylor CA

Patel K

Pham H

Abstract

In mid-June 2021, B.1.671.2 (Delta) became the predominant variant of SARS-CoV-2, the virus that causes COVID-19, circulating in the United States. As of July 2021, the Delta variant was responsible for nearly all new SARS-CoV-2 infections in the United States.* The Delta variant is more transmissib...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!